Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trialMatthew D. Galsky, Enrique Grande, Xavier García del Muro et al.|The Lancet|2020Cited by 786
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, George N. Thalmann, Shahrokh F. Shariat et al.|World Journal of Urology|2016Cited by 471
KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancerHaoyue Sheng, Dingwei Ye|Oncogene|2025Cited by 0